In recent years, the treatment spectrum for patients with inflammatory bowel disease (IBD) has expanded significantly. Based on the recognition that chronic and untreated inflammation adversely affects disease progression, early drug intervention and intensive monitoring are nowadays advocated to prevent complications.
This content is machine-translated. Please contact us if you need professional translation services.
Publikation
- HAUSARZT PRAXIS
